Not Yet Recruiting NA INTERVENTIONAL 2-arm NCT07415642

Dilated Cardiomyopathy - Unknown Therapeutic Risk Reduction by Contempary Medication and Implantable Cardioverter-Defibrillators (DUTCH-ICD) (DUTCH-ICD)

Using Cardiovascular Magnetic Resonance Identified Fibrosis to Assess Sudden Cardiac Death Risk in Patients With Non-ischemic Dilated Cardiomyopathy and the Unknown Therapeutic Risk Reduction of Contemporary Heart Failure Medication and Implantable Cardioverter-Defibrillators

Sponsor: Amsterdam University Medical Center

Conditions Sudden Cardiac Death

Interventions ICD implantation

Updated 1 time since 2026 Last updated: Feb 9, 2026 Started: Mar 1, 2026 Primary completion: Dec 31, 2032 Completion: Dec 31, 2032

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT07415642, this NA trial focuses on Sudden Cardiac Death and remains actively recruiting participants. Sponsored by Amsterdam University Medical Center, it has been updated 1 time since 2026, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

1 version recorded

Not Yet Recruiting — NA [monthly]

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Amsterdam University Medical Center
Radboud University Medical Center
University Medical Center Groningen

Data source: University Medical Center Groningen

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Groningen, Netherlands
• Nijmegen, Netherlands